We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A victory for genes.
- Abstract
The article deals with the U.S. Supreme Court's ruling on June 13, 2013 that human genes are unpatentable. The ruling invalidates claims by molecular diagnostics company Myriad Genetics in its patents on the breast cancer genes BRCA1 and BRCA2. The court used a section of the U.S. Code on patent law as a basis for its ruling on the case Association for Molecular Pathology et al. versus Myriad Genetics Inc. et al. It is noted that the ruling would benefit patients and the biotechnology industry.
- Subjects
UNITED States; UNITED States. Supreme Court; HUMAN genes; MYRIAD Genetics Inc.; GENETICS of breast cancer; PATENT law; ASSOCIATION for Molecular Pathology
- Publication
Nature Medicine, 2013, Vol 19, Issue 7, p792
- ISSN
1078-8956
- Publication type
Article
- DOI
10.1038/nm.3279